You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset
|
|---|---|
| Published in |
Frontiers in immunology, February 2022
|
| DOI | 10.3389/fimmu.2022.834316 |
| Pubmed ID | |
| Authors |
Roberto Russo, Giulia Gasparini, Emanuele Cozzani, Federica D’Agostino, Aurora Parodi |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | 15% |
| United States | 1 | 8% |
| Canada | 1 | 8% |
| Australia | 1 | 8% |
| Switzerland | 1 | 8% |
| Unknown | 7 | 54% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 10 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 3 | 30% |
| Student > Bachelor | 1 | 10% |
| Student > Postgraduate | 1 | 10% |
| Other | 1 | 10% |
| Unknown | 4 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 30% |
| Nursing and Health Professions | 1 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 10% |
| Unknown | 5 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2022.
All research outputs
#4,656,902
of 25,392,582 outputs
Outputs from Frontiers in immunology
#5,009
of 31,549 outputs
Outputs of similar age
#102,735
of 450,485 outputs
Outputs of similar age from Frontiers in immunology
#255
of 1,692 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,549 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,485 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 1,692 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.